Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment

Project Information

MHT-ImmunoEnhancer

Grant agreement ID: 843838

DOI

10.3030/843838

Project closed

EC signature date 28 March 2019

Start date 1 October 2019

End date 30 September 2021

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 183 473,28

EU contribution

€ 183 473,28

Coordinated by

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study

Author(s): Stefano Persano, Francesco Vicini, Alessandro Poggi, Jordi Leonardo Castrillo Fernandez, Giusy Maria Rita Rizzo, Helena Gavilán, Niccolo Silvestri, Teresa Pellegrino
Published in: Pharmaceutics, Issue 13/10, 2021, Page(s) 1668, ISSN 1999-4923
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics13101668

Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity

Author(s): Stefano Persano, Pradip Das, Teresa Pellegrino
Published in: Cancers, Issue 13/11, 2021, Page(s) 2735, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13112735